July 3, 2014
As The Stanford Hospital & Clinics Pharmacy & Therapeutics (P&T) Committee has added apixaban to the formulary. The Committee voted to remove sorafenib after results of a medication use evaluation were presented. Please click here for details.
Effective 7/12/2014, all specimens drawn that DO NOT MEET THE MINIMAL VOLUME requirement will be REJECTED. Click here for details.